Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Annals of Thoracic Surgery

Volumn 75, Issue 5, 2003, Pages 1622-1624

  Edwards, Jeff T ^a   Hamby, James K ^a   Worrall, Neil K ^a  

^a Heart Institute of Spokane   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; HEPARIN; ANTICOAGULANT AGENT; ANTITHROMBIN; PIPECOLIC ACID DERIVATIVE;

AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; COMORBIDITY; FATALITY; FEMALE; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MONITORING; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTOPENIA; CHEMICALLY INDUCED DISORDER; RISK FACTOR;

AGED; ANTICOAGULANTS; ANTITHROMBINS; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HUMANS; PIPECOLIC ACIDS; RISK FACTORS; THROMBIN TIME; THROMBOCYTOPENIA; WHOLE BLOOD COAGULATION TIME;

EID: 0037406344     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04782-3     Document Type: Article

References (9)

1. Bauer TL, Arepaly G, Konkele BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-6.
2. Sodden R, Loebe M, Garman KF, et al. Heparin-induced thrombocytopenia experiences in 12 heart surgery patients. ASAIO J 1997;43:M430-3.
3. Walls JT, Curtis JJ, Silver D. Heparin-induced thrombocytopenia in patients who undergo open heart surgery. Surgery 1990;108:686-93.
4. Furukawa K, Ohteki H, Hirabara K, Narita H, Koga S. The use of Argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J. Thorac Cardiovasc Surg 2001;122:1255-56.
5. Ohteki H, Furukawa K, Ohnishi H, et al. Clinical experience of argatroban for anticoagulation in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg 2000;48:39-4.
6. Moledina M, Chakir M, Gandhi PJ. A synopsis of the clinical uses of Argatroban. J Thromb Thrombolysis 2001;12:141-9.
7. Singer RL, Mannion JD, Bauer TL, et al. Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest 1993;104:1436-9.
8. Koster A, Kuppe H, Hetzer R, et al. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin. Anesthesiology 1998;89:777-80.
9. Chong BH. Heparin-induced thrombocytopenia. Br J Hematol 1995;89:431-9.